Cargando…

Novel urinary glycan profiling by lectin array serves as the biomarkers for predicting renal prognosis in patients with IgA nephropathy

In IgA nephropathy (IgAN), IgA1 molecules are characterized by galactose deficiency in O-glycans. Here, we investigated the association between urinary glycosylation profile measured by 45 lectins at baseline and renal prognosis in 142 patients with IgAN. The primary outcome was estimated glomerular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawakita, Chieko, Mise, Koki, Onishi, Yasuhiro, Sugiyama, Hitoshi, Yoshida, Michihiro, Yamada, Masao, Wada, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873239/ https://www.ncbi.nlm.nih.gov/pubmed/33564009 http://dx.doi.org/10.1038/s41598-020-77736-1

Ejemplares similares

Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy
por: Tanaka, Keiko, et al.
Publicado: (2023)

Renal expression of trefoil factor 3 mRNA in association with tubulointerstitial fibrosis in IgA nephropathy
por: Tanaka, Keiko, et al.
Publicado: (2018)

HIV-associated Immune Complex Kidney Disease with C3-dominant Deposition Induced by HIV Infection after Treatment of IgA Nephropathy
por: Kawakita, Chieko, et al.
Publicado: (2019)

Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy
por: Yasutake, Junichi, et al.
Publicado: (2015)

Enzymatic Sialylation of IgA1 O-Glycans: Implications for Studies of IgA Nephropathy
por: Takahashi, Kazuo, et al.
Publicado: (2014)

Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy
por: Zhao, Yan-feng, et al.
Publicado: (2017)

Correction: Enzymatic Sialylation of IgA1 O-Glycans: Implications for Studies of IgA Nephropathy
Publicado: (2014)

The possible involvement of intestine-derived IgA(1): a case of IgA nephropathy associated with Crohn’s disease
por: Terasaka, Tomohiro, et al.
Publicado: (2016)

Pathological Scenario with the Mannose-Binding Lectin in Patients with IgA Nephropathy
por: Ohsawa, Isao, et al.
Publicado: (2012)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Uncoupling of Glomerular IgA Deposition and Disease Progression in Alymphoplasia Mice with IgA Nephropathy
por: Aizawa, Masashi, et al.
Publicado: (2014)

Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy
por: Wada, Yukihiro, et al.
Publicado: (2018)

Nivolumab-induced IgA nephropathy in a patient with advanced gastric cancer: A case report
por: Tanabe, Katsuyuki, et al.
Publicado: (2020)

Differential expression of peptides serves as an indicator of IgA nephropathy in pediatric patients
por: Rao, Chunbao, et al.
Publicado: (2020)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Diagnostic Potential of Plasma IgA1 O-Glycans in Discriminating IgA Nephropathy From Other Glomerular Diseases and Healthy Participants
por: Zhang, Shuyu, et al.
Publicado: (2022)

IgA Nephropathy with Dominant IgA2 Deposition Accompanied by Mantle Cell Lymphoma
por: Kakeshita, Kota, et al.
Publicado: (2020)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Clinical Significance of the Intensity of Glomerular Galactose-Deficient IgA1 Deposition in IgA Nephropathy
por: Nakayama, Maiko, et al.
Publicado: (2022)

Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis
por: Suzuki, Hitoshi
Publicado: (2018)

Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy
por: Placzek, William J., et al.
Publicado: (2018)

Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy
por: Irabu, Hitoshi, et al.
Publicado: (2020)

Identification of IgA autoantibodies targeting mesangial cells redefines the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy
por: Lee, Mingfeng, et al.
Publicado: (2020)

cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy
por: Misaki, Taro, et al.
Publicado: (2023)

Utility of remission criteria for the renal prognosis of IgA nephropathy
por: Matsuzaki, Keiichi, et al.
Publicado: (2021)

Thrombotic Microangiopathy in IgA Nephropathy
por: Nasri, Hamid
Publicado: (2013)

Role of complement in IgA nephropathy
por: Daha, Mohamed R., et al.
Publicado: (2015)

Nutcracker phenomenon in IgA nephropathy
por: Imai, Naohiko, et al.
Publicado: (2014)

Idiopathic erythrocytosis in IgA nephropathy
por: Mahesh, E., et al.
Publicado: (2017)

Case Presentation – IgA Nephropathy
por: Williams, David L.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_3b6gmb7uj1g112iecb2ud78u1h